Pfizer announced Tuesday that a study found that its oral, antiviral COVID-19 pill Paxlovid reduced the risk of hospitalization or death by 89 percent in high-risk patients.Pfizer said that the 2,246 patients in the study were given the…
Copyright © 2024 | WordPress Theme by MH Themes